Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases
TenSixteen Bio is a biotechnology company focused on developing novel therapeutics for a variety of diseases.
Pardes Biosciences is a biotechnology company that develops and commercializes direct-acting antivirals for the treatment of coronavirus.
Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.
Tasso is a Medical innovation company changing the way diagnostics are delivered
Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics.
CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.
Myome helps identify genes that cause disease and act based on leading science.
Fulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.
Inscripta is a life science technology company that develops digital genome engineering solutions.
Replimune Group develop the next generation of ‘oncolytic immunotherapies’ for the treatment of cancer.
Velia is a biotech company that discovers and develops the therapeutic potential of human proteins.
Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.
Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel.
Nested Therapeutics aims to advance precision oncology medicine by finding new driver mutations.
Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.
Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.
Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.
AtaiBeckley develops innovative mental health treatments that address significant unmet medical needs.
Folx Health is a telehealth platform that provides digital healthcare services designed for the LGBTQIA+ community.
Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.
Seaport Therapeutics is a clinical-stage biopharmaceutical company that develops neuropsychiatric medicines.
Slate Medicines develops therapeutics that target Pituitary Adenylate Cyclase-Activating Polypeptide for migraine treatment and prevention.
Third Arc Bio is a biotech company developing multifunctional antibodies for inflammatory and immunology diseases.
Foresite Capital has invested in 129 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Foresite Capital's top investment sectors include Biotechnology, Health Care, Therapeutics, Life Science, Medical. The firm invests across 18 different industry categories.
Among tracked funding rounds, Wave Life Sciences received $350.0M in a Post-IPO Equity round. Foresite Capital's total known invested capital is $15.2B.
Foresite Capital's average investment size is $143.0M across its portfolio of 129 companies.
Recent Foresite Capital portfolio additions include Wave Life Sciences, TenSixteen Bio, Pardes Biosciences, Aeovian Pharmaceuticals, Tasso. These companies were founded in 2020 or later.